These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. BCG in bladder cancer. Meek D Nurs Times; 1994 Oct 26-Nov 1; 90(43):34-5. PubMed ID: 7984457 [TBL] [Abstract][Full Text] [Related]
7. Mycobacteremia and granulomatous hepatitis following initial intravesical bacillus Calmette-Guerin instillation for bladder carcinoma. Proctor DD; Chopra S; Rubenstein SC; Jokela JA; Uhl L Am J Gastroenterol; 1993 Jul; 88(7):1112-5. PubMed ID: 8317415 [TBL] [Abstract][Full Text] [Related]
8. BCG: A note of caution. Bluming AZ N Engl J Med; 1973 Oct; 289(16):860-1. PubMed ID: 4763431 [No Abstract] [Full Text] [Related]
9. BCG installations for bladder cancer and latent tuberculosis infection. Hanson K Urol Nurs; 2002 Apr; 22(2):132-4. PubMed ID: 11993243 [No Abstract] [Full Text] [Related]
10. [Miliary tuberculosis as a complication of BCG immunotherapy in cancer of the bladder. Case report]. Arrese M; Ebel L; Hofmann E; Gaete P; Jara A; Cabrera K; Araos F; Del Río P; Valdivieso V Rev Med Chil; 1992 Aug; 120(8):910-3. PubMed ID: 1340967 [TBL] [Abstract][Full Text] [Related]
11. BCG-RIVM: a new BCG preparation for intravesical immunotherapy of superficial bladder cancer. Schreinemachers L; Van der Meyden A; Steerenberg P; Feitz W; Groothuis D; De Jong W; Debruyne F Chemioterapia; 1987 Jun; 6(2 Suppl):713-6. PubMed ID: 3334665 [No Abstract] [Full Text] [Related]
12. [Granulomatous prostatitis after intravesical BCG immunotherapy of superficial bladder cancer: a case report]. Sai S; Sakakibara T; Takashi M; Sakata T; Miyake K Hinyokika Kiyo; 1990 Aug; 36(8):953-5. PubMed ID: 2239600 [TBL] [Abstract][Full Text] [Related]
13. [Treatment of the complications occurring in BCG vaccine immunotherapy of patients with malignant neoplasms]. Grigorovich NA; Risina DIa; Nodel'son SE Vopr Onkol; 1984; 30(7):102-6. PubMed ID: 6464396 [TBL] [Abstract][Full Text] [Related]
14. [Reiter syndrome after intravesical Bacillus Calmette-Guerin (BCG) immunotherapy: a case report]. Shiba M; Fujii T; Takatera H Hinyokika Kiyo; 2003 Oct; 49(10):599-601. PubMed ID: 14655604 [TBL] [Abstract][Full Text] [Related]
15. Disseminated BCG disease associated with immunotherapy by scarification in acute leukemia. Ritch PS; McCredie KB; Gutterman JU; Hersh EM Cancer; 1978 Jul; 42(1):167-70. PubMed ID: 276413 [TBL] [Abstract][Full Text] [Related]
16. [Disseminated infection due to Mycobacterium bovis alter intravesical instillation of BCG]. de la Iglesia Fanjul I; de Castro Losa MR; Mourad F; Bajo Franco T An Med Interna; 2007 Oct; 24(10):514-5. PubMed ID: 18333323 [No Abstract] [Full Text] [Related]
17. Systemic bacillus Calmette-Guerin infection in patients treated by intravesical BCG therapy for superficial bladder cancer. Steg A; Leleu C; Debré B; Boccon-Gibod L; Sicard D Prog Clin Biol Res; 1989; 310():325-34. PubMed ID: 2672020 [TBL] [Abstract][Full Text] [Related]
18. [BCG and immunotherapy for tumors. Prevention of adverse effects of BCG vaccination]. Lugosi L Orv Hetil; 1972 Mar; 113(13):757-9. PubMed ID: 5021351 [No Abstract] [Full Text] [Related]
19. Adjuvant immunotherapy in superficial bladder cancer. Morales A Natl Cancer Inst Monogr; 1978 Dec; (49):315-9. PubMed ID: 748787 [TBL] [Abstract][Full Text] [Related]
20. Chronic disseminated infection and intravesical bacillus Calmette-Guerin. Baxter JD; Hare GT N J Med; 1999 Jan; 96(1):50-2. PubMed ID: 9949659 [No Abstract] [Full Text] [Related] [Next] [New Search]